iSERA Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 8, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	1,210	464	219	22	0	12
Market Cap Growth	285964.05%	111.95%	917.05%	4951.17%	-96.41%	72.31%
Enterprise Value	1,198	480	221	23	0	31
Last Close Price	143.90	55.16	676.67	676.67	473.33	373.33
PE Ratio	466.48	178.81	157.45	-	-	-
PS Ratio	88.42	33.89	82.52	-	-	-
PB Ratio	14.67	5.62	-223.31	-9.95	-0.37	-263.13
P/TBV Ratio	14.67	5.62	-	-	-	-
EV/Sales Ratio	87.54	35.07	83.50	-	-	-
EV/EBIT Ratio	-	171.57	159.30	-	-	-
Debt / Equity Ratio	0.20	0.20	-16.38	-0.85	-1.08	-
Net Debt / Equity Ratio	-0.15	-0.15	-16.17	-0.85	-1.05	0.22
Net Debt / EBITDA Ratio	-	-	-	-	-	0.15
Net Debt / FCF Ratio	0.23	0.23	-1.13	-3.01	-0.99	0.00
Asset Turnover	0.23	0.23	0.33	-	-	-
Quick Ratio	6.32	6.32	7.22	0.02	0.07	0.18
Current Ratio	6.63	6.63	33.63	0.63	1.21	0.18
Return on Equity (ROE)	6.37%	6.37%	-	-	-	-
Return on Assets (ROA)	2.89%	2.89%	10.80%	-117.20%	-282.13%	-2.93%
Return on Invested Capital (ROIC)	3.06%	5.04%	18.84%	-	-5362.18%	-10.86%
Return on Capital Employed (ROCE)	2.80%	2.80%	9.20%	311.70%	-1314.70%	2338.30%
Earnings Yield	0.21%	0.56%	0.64%	-4.38%	-262.36%	-8.89%
FCF Yield	-	-11.54%	-6.40%	-2.82%	-289.57%	-25.27%
Buyback Yield / Dilution	-2525.54%	-2525.54%	-6.76%	-0.09%	-	-